• Jun 19, 2020
    The Centers for Medicare & Medicaid Services (CMS) has issued Permissive Action information to Medicare Advantage Organizations and Part D Sponsors to inform them of the obligations and permissible flexibilities related to disasters and emergencies resulting from COVID-19.
  • Jun 18, 2020
    The Department of Health and Human Services (HHS) expects to distribute $15 billion to eligible Medicaid and CHIP providers through the Coronavirus Aid, Relief and Economic Security (Cares) Act.
  • Jun 16, 2020
    Earlier this year IPC donated $25,000 to the National Conference of Insurance Legislators (NCOIL) for its 501(c)(3) Insurance Legislators Foundation. The donation for educational purposes will support NCOIL’s amicus brief in the U.S. Supreme Court case Rutledge v. PCMA. IPC backs the Arkansas position that its 2016 state MAC regulation law is not pre-empted by the federal 1974 Employer Retirement Income Security Act (ERISA).
  • May 27, 2020
    The need to establish pharmacists as public health providers has never been more important. We need to stress to Congress that community pharmacies are on the front lines assisting patients as they cope with this current pandemic crisis and beyond. Congress must take measures to ensure pharmacies remain viable and accessible to patients.
  • May 26, 2020
    The Paycheck Protection Program (PPP) has undoubtedly left some pharmacy owners confused about eligible expenses and loan forgiveness. Fortunately, the Small Business Administration and Treasury have issued additional information along with the PPP Forgiveness Application.
  • Apr 16, 2020
    A bipartisan letter, signed by Reps. Buddy Carter (R-Ga.), Peter Welch (D-Vt.), Raja Krishnamoorthi (D-Ill.), John Rose (R-Tenn.), Vicente Gonzales (D-Texas), and Doug Collins (R-Ga.), underscores independent community pharmacists essential role in addressing the COVID-19 pandemic and presses Congressional leadership to address pharmacy DIR fees in the next COVID-19 legislative package being negotiated.